ASEAN and India set the stage for a $70B+ MedTech opportunity 

Healthcare in Asia is changing fast. Across Southeast Asia and India, demand for better access, advanced treatments, and affordable solutions is fuelling an industry that just a decade ago was still finding its footing. Today, the MedTech sector in these regions is no longer peripheral — it is becoming central to global growth plans, with investors, manufacturers, and innovators looking to establish a strong foothold. 

ASEAN’s regional momentum 

ASEAN is rapidly building momentum as a MedTech hub. The region’s medical devices market exceeded US$19 billion in imports in 2024 and continues to expand. Ageing populations, an increase in chronic illnesses, and sustained investment in healthcare infrastructure are fuelling this rise. Countries across the region are ramping up capacity, and Singapore, in particular, has established itself as a centre for MedTech manufacturing, regulatory expertise, and research. For global players, ASEAN offers a fertile testing ground for new technologies and cost-effective models that can be scaled across diverse healthcare systems. 

India’s expanding MedTech market 

India’s MedTech sector is also on a steep upward trajectory. Valued at around US$12 billion in 2023–24, it is expected to grow more than fourfold to reach US$50 billion by 2030. This surge is being driven by government incentives for local production, a burgeoning middle class, and the pressing need for scalable healthcare solutions to serve a population of 1.4 billion. At the same time, India continues to rely heavily on imports for advanced medical technologies, with over 70 percent of high-end devices sourced internationally. This dependency underscores both the challenges and opportunities for local innovation and global collaboration. 

A region of opportunity and complexity 

Together, ASEAN and India present immense opportunities — vast populations in need of better care, growing healthcare spending, and governments aligning policy frameworks to attract investment. At the same time, the path is not without hurdles. Regulatory fragmentation across markets, high out-of-pocket healthcare costs, and the challenge of balancing affordability with innovation continue to test companies entering the space. Those able to navigate these complexities stand to benefit from one of the fastest-growing MedTech regions in the world.

MedTech World Singapore 2025 

Against this backdrop, MedTech World will host its Singapore Roadshow on 1 October 2025 in collaboration with KPMG Singapore. Designed as a platform to connect stakeholders from ASEAN, India, and beyond, the event will address some of the most pressing questions around regulation, investment, and innovation in MedTech. With Singapore’s position as a global hub, the conference will bring together leaders, policymakers, and innovators to explore how the region can meet rising healthcare needs while unlocking opportunities for sustainable growth. 

As Asia’s MedTech story accelerates, Singapore will provide the stage for charting its next chapter. 

To get involved, contact us at [email protected]. Book your tickets now!